These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35460628)

  • 1. Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2022 Sep; 227(3):440-461.e2. PubMed ID: 35460628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R; Rehal A; Brizot ML; Serra V; Da Fonseca E; Cetingoz E; Syngelaki A; Perales A; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2023 Dec; 229(6):599-616.e3. PubMed ID: 37196896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.
    Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R; Nicolaides KH
    Am J Obstet Gynecol; 2020 Jul; 223(1):42-65.e2. PubMed ID: 32027880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis.
    Boelig RC; Della Corte L; Ashoush S; McKenna D; Saccone G; Rajaram S; Berghella V
    Am J Obstet Gynecol MFM; 2019 Mar; 1(1):50-62. PubMed ID: 31172132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
    Saccone G; Khalifeh A; Elimian A; Bahrami E; Chaman-Ara K; Bahrami MA; Berghella V
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta-analysis.
    Care A; Nevitt SJ; Medley N; Donegan S; Good L; Hampson L; Tudur Smith C; Alfirevic Z
    BMJ; 2022 Feb; 376():e064547. PubMed ID: 35168930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
    EPPPIC Group
    Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestogens for preventing miscarriage: a network meta-analysis.
    Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
    Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
    Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
    Berghella V; Saccone G
    Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies.
    Eleje GU; Eke AC; Ikechebelu JI; Ezebialu IU; Okam PC; Ilika CP
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012871. PubMed ID: 32970845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.